Clinical Trial Update: Efficacy and Safety of NNC 0078-0000-0007 in Patients With Congenital Haemophilia and Inhibitors [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of NNC 0078-0000-0007 in patients with congenital haemophilia with inhibitors; results have been completed and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Bleeding Disorder
• Haemophilia with Inhibitors

Drugs mentioned

• NNC 0078-0000-0007 (NNC-0078-0000-0007)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Congenital Bleeding Disorder, Haemophilia A With Inhibitors | Phase 3 | Status: COMPLETED | Results posted: 2013-12-06